IDEXX Laboratories, Inc.
IDXX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $1,105,239 | $1,109,457 | $998,427 | $954,288 |
| % Growth | -0.4% | 11.1% | 4.6% | – |
| Cost of Goods Sold | $421,885 | $414,725 | $375,048 | $383,628 |
| Gross Profit | $683,354 | $694,732 | $623,379 | $570,660 |
| % Margin | 61.8% | 62.6% | 62.4% | 59.8% |
| R&D Expenses | $63,415 | $61,898 | $59,061 | $57,729 |
| G&A Expenses | $105,936 | $98,681 | $91,561 | $101,137 |
| SG&A Expenses | $265,093 | $259,788 | $247,784 | $251,245 |
| Sales & Mktg Exp. | $159,157 | $161,107 | $156,223 | $150,108 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $328,508 | $321,686 | $306,845 | $308,974 |
| Operating Income | $354,846 | $373,046 | $316,534 | $261,686 |
| % Margin | 32.1% | 33.6% | 31.7% | 27.4% |
| Other Income/Exp. Net | -$10,075 | -$10,694 | -$6,450 | -$5,299 |
| Pre-Tax Income | $344,771 | $362,352 | $310,084 | $256,387 |
| Tax Expense | $70,161 | $68,363 | $67,407 | $40,238 |
| Net Income | $274,610 | $293,989 | $242,677 | $216,149 |
| % Margin | 24.8% | 26.5% | 24.3% | 22.7% |
| EPS | 3.43 | 3.66 | 2.98 | 2.63 |
| % Growth | -6.3% | 22.8% | 13.3% | – |
| EPS Diluted | 3.4 | 3.63 | 2.96 | 2.62 |
| Weighted Avg Shares Out | 80,096 | 80,413 | 81,319 | 81,846 |
| Weighted Avg Shares Out Dil | 80,675 | 80,994 | 81,922 | 82,538 |
| Supplemental Information | – | – | – | – |
| Interest Income | $580 | $627 | $1,216 | $2,199 |
| Interest Expense | $10,655 | $11,321 | $7,666 | $7,498 |
| Depreciation & Amortization | $36,627 | $35,772 | $34,063 | $33,706 |
| EBITDA | $392,053 | $409,445 | $351,813 | $298,563 |
| % Margin | 35.5% | 36.9% | 35.2% | 31.3% |